Pink SheetThe US Food and Drug Administration has received largely negative reviews from industry for its proposal to require fixed-quantity unit-of-use blister packaging of certain opioid products, with many g
ScripAfter recently raising a Series B funding of $32m from Chinese investors, EOC Pharma is planning to expand its team in clinical development, regulatory affairs and CMC (chemistry, manufacturing, and c
Generics BulletinChina’s biosimilar market is expected to usher in a major breakthrough, following the launch of the first large scale collaborative partnership for biosimilars development between Amgen Inc. and
ScripChina’s biosimilar market is expected to usher in a major breakthrough, following the launch of the first large scale collaborative partnership for biosimilars development between Amgen Inc. and